Template:Clinically Utilized Antibiotics: Difference between revisions
No edit summary |
(Fix: Remove duplicate groupstyle parameter in β-lactams Navbox subgroup call) |
||
| (4 intermediate revisions by one other user not shown) | |||
| Line 24: | Line 24: | ||
* [[Dicloxacillin]] | * [[Dicloxacillin]] | ||
* [[Oxacillin]] | * [[Oxacillin]] | ||
* [[Nafcillin]] | * [[Nafcillin]] | ||
| Line 45: | Line 44: | ||
* [[Ertapenem]] | * [[Ertapenem]] | ||
* [[Doripenem]] | * [[Doripenem]] | ||
* [[Imipenem]] | * [[Imipenem/Cilastin]] | ||
* [[Meropenem]] | * [[Meropenem]] | ||
| group4= [[Cephalosporins]] | |||
| group4= [[Cephalosporins]] | |||
| list4= {{Navbox subgroup | | list4= {{Navbox subgroup | ||
| groupstyle = background-color: PowderBlue | | groupstyle = background-color: PowderBlue | ||
| Line 93: | Line 90: | ||
}} | }} | ||
| group3 = [[Aminoglycosides]] | | group3 = [[Aminoglycosides]] | ||
| Line 167: | Line 158: | ||
* [[Ciprofloxacin]] | * [[Ciprofloxacin]] | ||
* [[Ofloxacin]] | * [[Ofloxacin]] | ||
| group3 = 3rd g. | | group3 = 3rd g. | ||
| Line 189: | Line 179: | ||
* [[Metronidazole]] | * [[Metronidazole]] | ||
* [[Rifampin]] | * [[Rifampin]] | ||
* [[Vancomycin]] | |||
}}<noinclude> | }}<noinclude> | ||
Latest revision as of 14:40, 20 March 2026
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
hlist
How to manage this template's visibility
- Use
{{Clinically Utilized Antibiotics |state=collapsed}}to show this template in its collapsed (hidden) state. - Use
{{Clinically Utilized Antibiotics |state=expanded}}to show this template in its expanded (fully visible) state. - Use
{{Clinically Utilized Antibiotics |state=autocollapse}}to show this template in its collapsed (hidden) state only if there is another template of the same type on the page. - Unless set otherwise (see state parameter within the template's code), autocollapse is the default state.